Finance

Beta
Ask
Lists
506260:BOM
Anuh Pharma Ltd
₹79.52
+4.84%
(+3.67) 1D
Jun 12, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 506260...
Open
₹77.00
High
₹84.46
Low
₹77.00
Mkt. cap
7.97B
Avg. vol.
6.04K
Volume
54.45K
Dividend
1.89%
Quarterly dividend
₹0.38
Ex-dividend date
Aug 5, 2026
P/E ratio
19.40
52-wk high
₹115.00
52-wk low
₹66.72
EPS
₹4.10
Shares outstanding
25.06M
No. of employees
295
Open
₹77.00
High
₹84.46
Low
₹77.00
Mkt. cap
7.97B
Avg. vol.
6.04K
Volume
54.45K
Dividend
1.89%
Quarterly dividend
₹0.38
Ex-dividend date
Aug 5, 2026
P/E ratio
19.40
52-wk high
₹115.00
52-wk low
₹66.72
EPS
₹4.10
Shares outstanding
25.06M
No. of employees
295
News stories
From sources across the web
About Anuh Pharma Ltd
CEO-
Employees295
Founded1960
Headquarters-
SectorPharmaceutical industry
Websiteanuhpharma.com
Last report
May 20, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
2.02B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.86B
1.86B
1.97B
2.02B
Cost of goods sold
1.53B
1.45B
1.51B
1.51B
Cost of revenue
1.53B
1.45B
1.51B
1.51B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62.98M
67.46M
69.11M
63.49M
Operating expense
260.79M
323.32M
321.02M
340.11M
Total operating expenses
1.79B
1.77B
1.83B
1.85B
Operating income
77.76M
90.18M
137.98M
168.80M
Other non operating income
33.88M
9.78M
41.10M
-12.55M
EBT including unusual items
109.53M
99.21M
178.28M
155.20M
EBT excluding unusual items
109.53M
99.21M
178.28M
155.20M
Income tax expense
26.52M
23.08M
43.77M
38.38M
Effective tax rate
24.21%
23.27%
24.55%
24.73%
Other operating expenses
172.66M
227.24M
221.89M
246.59M
Net income
83.01M
76.12M
134.51M
116.81M
Net profit margin
4.45%
4.10%
6.82%
5.78%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.11M
-756.00K
-796.00K
-1.06M
Net interest expenses
-2.11M
-756.00K
-796.00K
-1.06M
Depreciation and amortization charges
25.15M
28.62M
30.02M
30.03M
EBITDA
98.32M
117.06M
158.54M
197.25M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer